doi: 10.1038/ng1156.
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
Affiliations
- PMID: 12717436
- DOI: 10.1038/ng1156
Item in Clipboard
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
Nat Genet.
2003 Jun.
Abstract
We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML. Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML). Functional analyses documented that the two most common mutations in PTPN11 associated with JMML caused a gain of function.
Similar articles
-
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.Cancer Res. 2004 Dec 15;64(24):8816-20. doi: 10.1158/0008-5472.CAN-04-1923. Cancer Res. 2004. PMID: 15604238
-
Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.Genes Chromosomes Cancer. 2006 Jun;45(6):583-91. doi: 10.1002/gcc.20322. Genes Chromosomes Cancer. 2006. PMID: 16518851
-
Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations.Genes Chromosomes Cancer. 2007 Jun;46(6):517-21. doi: 10.1002/gcc.20426. Genes Chromosomes Cancer. 2007. PMID: 17330262
-
Mutations of PTPN11 are rare in adult myeloid malignancies.Haematologica. 2005 Jun;90(6):853-4. Haematologica. 2005. PMID: 15951301 Review.
-
PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes.Pediatr Endocrinol Rev. 2005 Jun;2(4):669-74. Pediatr Endocrinol Rev. 2005. PMID: 16208280 Review.
Cited by
-
Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies.Mol Cancer Ther. 2013 Sep;12(9):1738-48. doi: 10.1158/1535-7163.MCT-13-0049-T. Epub 2013 Jul 3. Mol Cancer Ther. 2013. PMID: 23825065 Free PMC article.
-
Juvenile xanthogranuloma in Noonan syndrome.Am J Med Genet A. 2021 Oct;185(10):3048-3052. doi: 10.1002/ajmg.a.62353. Epub 2021 May 25. Am J Med Genet A. 2021. PMID: 34032360 Free PMC article.
-
Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies.Cells. 2024 Jan 25;13(3):231. doi: 10.3390/cells13030231. Cells. 2024. PMID: 38334623 Free PMC article. Review.
-
Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment.Cancers (Basel). 2020 Sep 29;12(10):2799. doi: 10.3390/cancers12102799. Cancers (Basel). 2020. PMID: 33003469 Free PMC article. Review.
-
SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities.Cell Mol Life Sci. 2023 Dec 12;81(1):5. doi: 10.1007/s00018-023-05052-8. Cell Mol Life Sci. 2023. PMID: 38085330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
